DIETARY FIBERS IN THE CORRECTION OF DYSLIPIDEMIA IN PATIENTS WITH HEPATIC STEATOSIS
- 作者: Professor E.1
-
隶属关系:
- A.I. Evdokimov Moscow State University of Medicine and Dentistry
- 期: 卷 25, 编号 12 (2014)
- 页面: 22-26
- 栏目: Articles
- URL: https://journals.eco-vector.com/0236-3054/article/view/116133
- ID: 116133
如何引用文章
开放存取
##reader.subscriptionAccessGranted##
详细
The paper gives information on the value of dietary fibers for the correction of metabolic syndrome (MS) manifestations. The author describes her own experience with a dietary fiber medicine (Mucofalk) in patients with MS, hepatic steatosis, and lipid metabolic disturbance.
全文:
作者简介
E. Professor
A.I. Evdokimov Moscow State University of Medicine and Dentistry
Email: golovanovaev@mail.ru
Professor, MD Central Research Institute of Gastroenterology
参考
- Голованова Е.В. Тиогамма при неалкогольной жировой болезни печени // Фарматека. - 2012; 7 (240): 53-7.
- Голованова Е.В., Ковязина И.О., Шапошникова Н.А. Рациональная фармакотерапия неалкогольного стеатогепатита. // Вестн. семейной медицины. -2010; 2: 54-9.
- Драпкина O.M., Смирин В.И., Ивашкин B.T. Патогенез, лечение и эпидемиология НАЖБП - что нового? Эпидемиология НАЖБП в России // РМЖ. -2011; 28: 1717-21.
- Лазебник Л.Б., Голованова Е.В., Ковязина И.О. и др. Эссенциальные фосфолипиды в терапии неалкогольных стеатогепатитов // Consilium Medicum. - 2007; 9 (7): 23-8.
- Чиркин В.И., Лазарев И.А., Ардатская М.Д. Долгосрочные эффекты препарата пищевых волокон псиллиума (Мукофальк) у пациентов с метаболическим синдромом // Клин. перспективы в гастроэнтерол., гепатол. - 2012; 1: 34-42.
- Abel E. Moreyra, Alan C. et al. Effekt of Combining Psyllium Fiber With Simvastatin in Lowering Cholesterol // Apch Intern. Med. - 2005; 165: 1161-6.
- Anderson J. et al. Cholesterol-lowering effects of psyllium hydrophilic mucilloid for hypercholesterolemic men // Arch. Intern. Med. - 1988; 148 (2): 292-6.
- Anderson J. et al. Cholesterol-lowering effects of psyllium intake adjunctive to diet therapy in men and women with hypercholesterolemia: meta-analysis of 8 controlled trials // Am. J. Clin. Nutr. - 2000; 71 (2): 472-9.
- Dongiovanni P., Valenti L., Rametta R. et al. Genetic variants regulating insulin receptor signaling are associated with the severity of liver damage in patients with non-alcoholic fatty liver disease // Gut. - 2010; 59: 267-73.
- Judith A. Marlett, Milton H. Fischer The active fraction of psyllium seed husk // Proceedings of the Nutrition Society. - 2003; 62: 207-9.
- Kleiner D., Brunt E., Van Natta M. et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease // Hepatology. -2005; 41: 1313-21.
- Leuschner U., James O., Dancygier H. Steatohepatitis / NASH and ASH: Springer, 2004; р. 35.
- Loos R., Savage D. Inherited susceptibility to non-alcoholic fatty liver disease // Diabetologia. - 2009; 52: 1000-2.
- Oliveira Claudia Pinto Marques Souza, Stefano Jose Tadeu, Ana Mercedes Cavaleiro Ana Mercedes et al. Association of polymorphisms of glutamate-cystein ligase and microsomal triglyceride transfer protein genes in non-alcoholic fatty liver disease // J. Gastroenterol. Hepatol. - 2010; 25: 357-61.
- Powell et al.; Lee et al.; Bacon et al.; Falk-Ytter et al.
- Zheng Lin, Lv Guo-cai, Sheng Jifang, Yang Yi-da. Effect of miRNA-10b in regulating cellular steatosis level by targeting PPAR-alpha expression, a novel mechanism for the pathogenesis of NAFLD // J. Gastroenterol. Hepatol. - 2010; 25: 156-63.
补充文件
